ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,001Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 3734

$1.21M Total Retail Price of All Prescriptions

Rank: 42 out of 3734

627 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 627 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 627 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 20,849 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL TARTRATE 822 792 1 6
LEVOTHYROXINE SODIUM 746 683 2 2
AMLODIPINE BESYLATE 722 715 3 5
OMEPRAZOLE 682 650 4 4
SIMVASTATIN 612 604 5 1
FUROSEMIDE 523 519 6 7
METFORMIN HCL 451 420 7 8
WARFARIN SODIUM 443 440 8 10
CITALOPRAM HBR 443 434 8 16
HYDROCHLOROTHIAZIDE 440 420 10 9
LISINOPRIL 414 406 11 3
POLYETHYLENE GLYCOL 3350 394 360 12 53
LOVASTATIN 377 364 13 41
ATORVASTATIN CALCIUM 356 339 14 11
GABAPENTIN 353 325 15 17
POTASSIUM CHLORIDE 331 326 16 19
METOPROLOL SUCCINATE 315 300 17 14
HYDROCODONE-ACETAMINOPHEN 301 262 S3 18 12
ISOSORBIDE MONONITRATE ER 300 294 19 34
SERTRALINE HCL 289 288 20 18
TRAMADOL HCL 285 264 21 20
FENOFIBRATE 263 257 22 81
ATENOLOL 257 257 23 13
NAMENDA 244 244 24 44
GLIMEPIRIDE 243 240 25 37
ALENDRONATE SODIUM 235 230 26 26
PANTOPRAZOLE SODIUM 231 220 27 22
TAMSULOSIN HCL 218 204 28 29
PRAVASTATIN SODIUM 218 207 28 15
LOSARTAN POTASSIUM 214 211 30 21
DIGOXIN 192 190 31 43
CRESTOR 189 189 32 28
CLOPIDOGREL 186 184 33 23
ZOLPIDEM TARTRATE 179 173 34 24
FENTANYL 179 158 S2 34 65
DONEPEZIL HCL 175 175 36 25
SPIRIVA 167 165 37 40
FINASTERIDE 165 162 38 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 159 152 39 27
CARBIDOPA-LEVODOPA 157 157 40 92
FLUTICASONE PROPIONATE 154 122 41 46
MIRTAZAPINE 154 142 41 45
PREDNISONE 151 144 43 42
NEXIUM 151 147 43 36
PLAVIX 140 140 45 39
CARVEDILOL 133 123 46 30
MELOXICAM 130 124 47 52
ALLOPURINOL 126 126 48 33
CYMBALTA 121 93 49 67
LOSARTAN-HYDROCHLOROTHIAZIDE 112 108 50 71
TRIAMCINOLONE ACETONIDE 106 92 51 131
ESCITALOPRAM OXALATE 105 83 52 68
AZITHROMYCIN 104 95 53 38
LANTUS 102 102 54 54
TRAZODONE HCL 95 81 55 49
ROPINIROLE HCL 92 79 56 118
ADVAIR DISKUS 91 89 57 35
ZETIA 91 91 57 55
BENICAR 86 86 59 107
LIPITOR 86 81 59 90
NYSTATIN 81 81 61 162
OXYBUTYNIN CHLORIDE 79 79 62 151
PAROXETINE HCL 79 79 62 59
PEN NEEDLE 77 77 64 152
KLOR-CON 10 72 60 65 140
HUMALOG 71 71 66 146
RANITIDINE HCL 70 47 67 32
GLYBURIDE 67 67 R 68 64
KLOR-CON M20 64 63 69 48
PROAIR HFA 64 59 69 83
COMBIVENT 63 62 71 156
DILTIAZEM 24HR ER 63 63 71 86
VENLAFAXINE HCL ER 61 61 73 84
ZOSTAVAX 59 53 74 144
CELEBREX 58 48 75 69
SYNTHROID 58 44 75 47
DIOVAN 57 57 77 31
AMITIZA 56 44 78 238
AMOXICILLIN 55 51 79 108
DILTIAZEM 24HR CD 55 55 79 97
JANTOVEN 55 55 79 76
INSULIN SYRINGE 54 54 82 109
JANUVIA 54 43 82 50
LANTUS SOLOSTAR 53 53 84 102
ACTONEL 51 51 85 188
NITROSTAT 50 50 86 237
SUCRALFATE 50 50 86 225
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.